Participant 9. University of Strasbourg, Faculty of Pharmacy, Illkirch, France

The University of Strasbourg (UdS) is a scientific, cultural and professional public institution, which enjoys legal status and educational, scientific, administrative and financial autonomy (www.unistra.fr). European by nature and international by design, the University's strengths and assets stem from its active involvement in virtually every discipline comprising the current body of knowledge. The origins of the University of Strasbourg date back to the early 16th century when Jean Sturm created an institution where one could study theology, philosophy, medicine and law. Each of the University's main academic fields of instruction is based upon research sections that are the driving force of the institution, with over 2,600 professors and staff. Thanks to the worldwide reputation of its teams, research is a major asset for the University's development. The scale of research activity at Strasbourg is substantial, involving a European Doctoral College, 10 doctoral schools and 77 research units (unistra.fr). The Technology Transfer Office, one of the very first developed in a French university, strives to promote the work of the researchers and facilitate partnerships with economic and institutional stakeholders (servalor.unistra.fr).

The Campus of Illkirch, where the Faculty of Pharmacy (fac-pharma.u-strasbg.fr) is  located, is one of the major poles of the interface chemistry-biology in France and Europe, both quantitatively and qualitatively. Our teams hold a place of importance at the chemistry-biology interface, developing original research tools and molecules of therapeutic interest, while taking part in the fine and integrative comprehension of complex biological mechanisms. This research brought us successful technology transfers (Neuro3D, Euroclide/FAUST, Prestwick, Slowave, Greenpharma, Neuromedics, IDEALP Pharma, Phytodia). The Department of Pharmacognosy, to whom we belong, is a component of the "Laboratoire d'Innovation Thérapeutique" UMR 7200 of CNRS. We currently gather 4 qualified teams in organic synthesis, medicinal chemistry, molecular modeling and pharmacognosy under the leadership of Pr. Marcel Hibert (medchem.u-strasbg.fr).

Role in the project

Bioactivity testing (WP 3), Screening and application development: Preliminary screening of the compound fractions (apoptosis and TNF-a) and additional screening of the isolated compounds.

Dr. Christian D. MULLER

Dr. Ès Sciences (1988), Ph.D. In Pharmacology (1983)

Group leader, CR 1, CNRS

Faculty of Pharmacy

Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Expertise: His research in pharmacology covers especially the fields of cytomic applied to drug discovery.

Dr. Jean Peluso

Ph.D. in Molecular and Cellular Biology (1999)

Research Engineer

UMR 7200 CNRS, Faculty of Pharmacy

Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Expertise: He as an industrial background in "Extraction/Purification of small molecules" as Project Leader at ENTOMED SA, Illkirch, France from 1999-2004 and since 2005 he does Cytomic High Content Screening in vitro assay development for drug discovery.